GlassScriptPhysician profile
Amber L Downes
NPI 1801811419
$1,244.41
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,084 · 2022: $136 · 2023: $17.47 · 2024: $6.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $153.06 | 2021-2022 | |
| Abbvie INC. | $134.13 | 2021 | |
| Novo Nordisk INC | $132.60 | 2021 | |
| Glaxosmithkline, LLC. | $72.51 | 2021 | |
| Pfizer INC. | $63.63 | 2021 | |
| Lilly USA, LLC | $60.00 | 2021 | |
| Genentech USA, INC. | $49.36 | 2021-2022 | |
| Abbott Laboratories | $47.72 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $37.57 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.06 | 2021 | |
| Janssen Pharmaceuticals, INC | $29.35 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.70 | 2021 | |
| Organon LLC | $24.19 | 2023-2024 | Nexplanon |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $21.91 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.59 | 2021 | |
| Mylan Specialty L.P. | $21.39 | 2021 | |
| Seqirus USA INC | $19.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.69 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.02 | 2021 | |
| Amarin Pharma, INC. | $14.86 | 2021 | |
| Astellas Pharma US INC | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Downes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.